172 related articles for article (PubMed ID: 9523987)
1. Crystal forms of piroxicam pivalate: preparation and characterization of two polymorphs.
Giordano F; Gazzaniga A; Moyano JR; Ventura P; Zanol M; Peveri T; Carima L
J Pharm Sci; 1998 Mar; 87(3):333-7. PubMed ID: 9523987
[TBL] [Abstract][Full Text] [Related]
2. Characterization of two polymorphs of lornoxicam.
Zhang J; Tan X; Gao J; Fan W; Gao Y; Qian S
J Pharm Pharmacol; 2013 Jan; 65(1):44-52. PubMed ID: 23215687
[TBL] [Abstract][Full Text] [Related]
3. (14) N nuclear quadrupole resonance study of piroxicam: confirmation of new polymorphic form V.
Lavrič Z; Pirnat J; Lužnik J; Puc U; Trontelj Z; Srčič S
J Pharm Sci; 2015 Jun; 104(6):1909-1918. PubMed ID: 25776345
[TBL] [Abstract][Full Text] [Related]
4. Structural characterization of two polymorphic forms of piroxicam pivalate.
Caira MR; Zanol M; Peveri T; Gazzaniga A; Giordano F
J Pharm Sci; 1998 Dec; 87(12):1608-14. PubMed ID: 10189275
[TBL] [Abstract][Full Text] [Related]
5. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
Maghsoodi M; Sadeghpoor F
Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
[TBL] [Abstract][Full Text] [Related]
6. Thermal, spectroscopic, and ab initio structural characterization of carprofen polymorphs.
Bruni G; Gozzo F; Capsoni D; Bini M; Macchi P; Simoncic P; Berbenni V; Milanese C; Girella A; Ferrari S; Marini A
J Pharm Sci; 2011 Jun; 100(6):2321-32. PubMed ID: 21246561
[TBL] [Abstract][Full Text] [Related]
7. Solid state transformations in consequence of electrospraying--a novel polymorphic form of piroxicam.
Nyström M; Roine J; Murtomaa M; Mohan Sankaran R; Santos HA; Salonen J
Eur J Pharm Biopharm; 2015 Jan; 89():182-9. PubMed ID: 25483892
[TBL] [Abstract][Full Text] [Related]
8. Solid-state characterization of mefenamic acid.
Panchagnula R; Sundaramurthy P; Pillai O; Agrawal S; Raj YA
J Pharm Sci; 2004 Apr; 93(4):1019-29. PubMed ID: 14999737
[TBL] [Abstract][Full Text] [Related]
9. Polymorphic form of piroxicam influences the performance of amorphous material prepared by ball-milling.
Naelapää K; Boetker JP; Veski P; Rantanen J; Rades T; Kogermann K
Int J Pharm; 2012 Jun; 429(1-2):69-77. PubMed ID: 22433471
[TBL] [Abstract][Full Text] [Related]
10. Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate.
Ambrogi V; Perioli L; Marmottini F; Giovagnoli S; Esposito M; Rossi C
Eur J Pharm Sci; 2007 Nov; 32(3):216-22. PubMed ID: 17826966
[TBL] [Abstract][Full Text] [Related]
11. Studies on aging piroxicam-polyvinylpyrrolidone solid dispersions.
Ingkatawornwong S; Kaewnopparat N; Tantishaiyakul V
Pharmazie; 2001 Mar; 56(3):227-30. PubMed ID: 11265589
[TBL] [Abstract][Full Text] [Related]
12. The dissolution enhancement of piroxicam in its physical mixtures and solid dispersion formulations using gluconolactone and glucosamine hydrochloride as potential carriers.
Al-Hamidi H; Obeidat WM; Nokhodchi A
Pharm Dev Technol; 2015 Jan; 20(1):74-83. PubMed ID: 24392858
[TBL] [Abstract][Full Text] [Related]
13. Piroxicam/2-hydroxypropyl-beta-cyclodextrin inclusion complex prepared by a new fluid-bed coating technique.
Zhang X; Wu D; Lai J; Lu Y; Yin Z; Wu W
J Pharm Sci; 2009 Feb; 98(2):665-75. PubMed ID: 18543294
[TBL] [Abstract][Full Text] [Related]
14. Crystal modifications and dissolution rate of piroxicam.
Lyn LY; Sze HW; Rajendran A; Adinarayana G; Dua K; Garg S
Acta Pharm; 2011 Dec; 61(4):391-402. PubMed ID: 22202198
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical characterizations of piroxicam-poloxamer solid dispersion.
Shin SC; Cho CW
Pharm Dev Technol; 1997 Nov; 2(4):403-7. PubMed ID: 9552469
[TBL] [Abstract][Full Text] [Related]
16. Influence of structure on the spectroscopic properties of the polymorphs of piroxicam.
Liu W; Wang WD; Wang W; Bai S; Dybowski C
J Phys Chem B; 2010 Dec; 114(49):16641-9. PubMed ID: 21086973
[TBL] [Abstract][Full Text] [Related]
17. Influence of cyclodextrin complexation on piroxicam gel formulations.
Jug M; Bećirević-Laćan M; Kwokal A; Cetina-Cizmek B
Acta Pharm; 2005 Sep; 55(3):223-36. PubMed ID: 16375834
[TBL] [Abstract][Full Text] [Related]
18. Preparation and crystal characterization of a polymorph, a monohydrate, and an ethyl acetate solvate of the antifungal fluconazole.
Caira MR; Alkhamis KA; Obaidat RM
J Pharm Sci; 2004 Mar; 93(3):601-11. PubMed ID: 14762899
[TBL] [Abstract][Full Text] [Related]
19. Solid-state properties and crystallization behavior of PHA-739521 polymorphs.
Sun CC
Int J Pharm; 2006 Aug; 319(1-2):114-20. PubMed ID: 16720086
[TBL] [Abstract][Full Text] [Related]
20. Preparation, structural analysis, and properties of tenoxicam cocrystals.
Patel JR; Carlton RA; Needham TE; Chichester CO; Vogt FG
Int J Pharm; 2012 Oct; 436(1-2):685-706. PubMed ID: 22841852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
